Summary

Other Scenarios:

Buyer: Baxter International Inc. (BAX) Last Price: 49.49 Market Cap.: 28.84B
Target: Natus Medical, Inc. (BABY) Last Price: 15.42 Market Cap.: 445.78M

Lines of Business Summary:

Product Summary:

Overlap & Complementary Sectors

Sector Buyer Target # of Focused Companies
Healthcare 784
Biopharmaceuticals   347
Healthcare Services   138
Medical Devices 192
Nutritional Health   30
Outsourced Biomedical Services   41

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Sample Products in Similar Lines of Business

Sample Products in Complementary Lines of Business
Buyer (Total: 148)
  • Physiometrix Patient State Analyzer (PSA) 4000
  • Baxter Breathing Bag Series
  • Ultra-Fit Anesthesia Face Mask Series
  • Baxter Renal Care
Target (Total: 68)
  • Hawaii Medical NeatNick Lancet
  • Sonamed Clarity Screener
  • Centor
  • HINT Pro Hearing in Noise Test
Buyer
  • Phenergan (Promethazine)
  • Diphenhydramine
  • Promethazine Hydrochloride/Dextromethorphan Hydrochloride
  • Phenergan With Dextromethorphan (Promethazine Hydrochloride/Dextromethorphan Hydrochloride)
Target

n/a

Business Relationship Summary:

Top Key Suppliers

Top Key Customers
Buyer (Total: 12)
  • CA, Inc. (CA)
  • Computer Sciences Corporation (CSC)
  • Ariba, Inc. (ARBA)
  • Nektar Therapeutics (NKTR)
Target (Total: 0)

n/a
Buyer (Total: 13)
  • DaVita Inc. (DVA)
  • United Therapeutics Corporation (UTHR)
  • Amylin Pharmaceuticals, Inc. (AMLN)
  • Cerus Corporation (CERS)
Target (Total: 2)
  • VHA, Inc.
  • Premier, Inc.

Key Financial Summary:

Key Metrics

  Buyer Target
Number of Employees 49,700 635
Revenue Per Employee 260,189.7 333,908.6
Total Revenue 3,224.0 53.3
Total Expenses 2,442.0 47.4
Other Revenue 0.0 0.0
Cost of Revenue 1,565.0 21.8
SG&A Expense 670.0 20.8
Research & Development 207.0 4.8
Other Operating Expense 0.0 0.0
Operating Income 782.0 5.9
Unusual Income 0.0 0.0
LT Debt to Capital 40.03 0.3
Fwd P/E 12.73 24.98
Fwd P/Rev 2.26 2.07
Book Value 6,531.0 256.1
Curr Portion of LTD/Cap Lease 508.0 0.2

Individual Company Summary

Focused

Buyer

Focused (): Healthcare > Medical Devices

Target

Focused (): Healthcare > Medical Devices > Neonatology

Business Description

Buyer

Baxter International Inc. (Baxter) through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter manufactures products in 27 countries and sells them in more than 100 countries. The Company operates in three segments: BioScience, Medication Delivery and Renal. Baxter generates approximately 60% of its revenues outside the United States, and maintains manufacturing and distribution facilities in a number of locations in the United States, Europe, Canada, Asia-Pacific and Latin America. In August 2009, the Company acquired certain assets of Edwards Lifesciences Corporation related to the hemofiltration business, also known as Continuous Renal Replacement Therapy (Edwards CRRT).

Target

Natus Medical Incorporated (Natus) is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Its product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories. Natus categorizes its products into three categories: Hearing, Monitoring Systems for Neurology and Newborn Care.

Deal Summary

Key Ratios

  Buyer Target
Gross Margin % 47.66 59.01
Operating Margin % 18.31 7.39
Quick Ratio 1.19 2.89
Current Ratio 1.94 4.11
Coverage Ratio -0.04 -0.02
Total Assets 17,563.0 300.3
Return on Equity % 24.15 4.23
Return on Assets % 8.98 3.61
Cash+ ST Inv. Per Share 4.75 1.49
Total Debt 4,883.0 1.0
Total Debt to Equity % 74.77 0.38
Total Debt to Tangible Equity % 109.17 0.99
Debt to Asset % 27.80 0.32

Product Summary

Sector Buyer Target
Healthcare
Biopharmaceuticals  
Allergies
The Allergies Subsector includes therapeutics that treat exaggerated immune reaction induced by exposure to a foreign substance.
  
Cardiovascular System
The Cardiovascular System Subsector includes therapeutics that treat disorders affecting the heart and blood vessels.
  
Digestive System
The Digestive System Subsector includes therapeutics that treat disorders affecting the digestive system.
  
Endocrinology/Metabolism
The Endocrinology/Metabolism Subsector includes therapeutics that treat metabolic disorders and conditions resulting from the dysfunction of hormone secreting glands.
  
Hematology
The Hematology Subsector includes therapeutics that treat blood-based diseases and disorders.
  
Immunology
The Immunology Subsector includes therapeutics that treat disorders affecting the immune system.
  
Infectious Diseases
The Infectious Diseases Subsector includes therapeutics that treat diseases caused by the invasion and reproduction of microorganisms in the body.
  
Musculoskeletal System
The Musculoskeletal System Subsector includes therapeutics that treat disorders of the bones, joints, ligaments, tendons, and soft tissue involved with them.
  
Neurology
The Neurology Subsector includes therapeutics that treat disorders of the central nervous system, including the brain, spinal cord, and nerves.
  
Oncology
The Oncology Subsector includes therapeutics that treat and manage various types of cancer and related complications.
  
Pain Management
The Pain Management Subsector includes therapeutics that treat and management pain.
  
Respiratory System
The Respiratory System Subsector includes therapeutics that treat disorders affecting both the upper and lower respiratory tract, including the nose, throat, larynx, trachea, bronchi, and lungs.
  
Surgery
The Surgery Subsector includes therapeutics that treat complications associated with surgical procedures.
  
Toxicology
The Toxicology Subsector includes therapeutics that treat harmful effects from exposure to toxic substances; narcotics, nicotine and alcohol withdrawal therapeutics are also included in this sector.
  
Urology
The Urology Subsector includes therapeutics that treat diseases of the kidney, urinary tract, bladder, and the male reproductive system.
  
Healthcare Services  
Patient Care
The Patient Care Subsector is comprised of companies that provide services to patients for the diagnosis, treatment, and/or prevention of diseases and injuries.
  
Medical Devices
Anesthesiology
The Anesthesiology Subsector includes medical devices that deliver and monitor anesthetics.
  
Cardiology
The Cardiology Subsector includes medical devices that diagnose, monitor, and treat diseases affecting the heart and proximal blood vessels. Common devices include vital sign monitors, cardiac defibrillators, pacemakers, and other surgical equipment.
  
Clinical Diagnostics
The Clinical Diagnostics Subsector includes medical devices that analyze human body specimens within a medical setting. These devices, including equipment, biological and chemical reagents are primarily used for the diagnosis of diseases.
  
Drug Delivery
The Drug Delivery Subsector includes medical devices that facilitate the delivery of medications through different anatomical entryways, including blood vessels, skin, the mouth, and the lungs. Common devices in this sector include vascular access catheters, needles, implants, and inhalers.
  
Ear/Nose/Throat (ENT)
The Ear/Nose/Throat Subsector includes medical devices that diagnose and treat conditions affecting these anatomical regions.
  
Gastroenterology
The Gastroenterology Subsector includes medical devices that diagnosis and treat conditions affecting the stomach and intestinal tract.
  
General Surgery
The General Surgery Subsector includes medical devices that perform general, non-specialty surgeries; these devices are often general in scope and are used in procedures involving various parts of the body.
  
Medical Supplies
The Medical Supplies Subsector includes basic and consumable products that are widely used in healthcare settings.
Neonatology
The Neonatology Subsector includes medical devices that diagnose, monitor and treat diseases of newborns.
  
Neurology
The Neurology Subsector includes medical devices that diagnose, monitor and treat neurological disorders.
Ophthalmology
The Ophthalmology Subsector includes medical devices that diagnose and treat eye disorders.
  
Orthopedics
The Orthopedics Subsector includes medical devices that diagnose and treat musculoskeletal diseases involving muscles, bones and joints.
  
Respiratory
The Respiratory Subsector includes medical devices that diagnose and treat respiratory diseases.
Transfusion Medicine
The Transfusion Medicine Subsector includes medical devices and accessories that prepare or implement blood transfusion.
  
Urology
The Urology Subsector includes medical that diagnose and treat urinary tract and male reproductive disorders.
  
Vascular
The Vascular Subsector includes medical devices that diagnose and treat of conditions affecting the blood vessels.
  
Nutritional Health  
Dietary/Naturopathic Supplements
The Dietary/Naturopathic Subsector includes nutritional biochemicals and nutrients derived from natural sources that are intended to support health.
  
Outsourced Biomedical Services  
Development/Manufacturing Services
The Development/Manufacturing Services Subsector includes companies that provide research, development, manufacturing, sales and marketing to biopharmaceutical and medical device companies.
  

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Product Details

Sector Buyer Target
Healthcare
Biopharmaceuticals  
Allergies  
Dermatology  
Antihistamines
Products that inhibit inflammation by blocking the action of histamines on tissues.

Buyer Products:

  • Phenergan (Promethazine)
  
Ophthalmology  
Antihistamines
Therapeutics that inhibit inflammation by blocking the action of histamines on tissues.

Buyer Products:

  • Phenergan (Promethazine)
  
Upper Respiratory  
Antihistamines
Therapeutics that inhibit the inflammation by blocking the action of histamines on tissues.

Buyer Products:

  • Phenergan (Promethazine)
  • Diphenhydramine
  
Antihistamines/Antitussives
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.

Buyer Products:

  • Promethazine Hydrochloride/Dextromethorphan Hydrochloride
  • Phenergan With Dextromethorphan (Promethazine Hydrochloride/Dextromethorphan Hydrochloride)
  
Antihistamines/Decongestants
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.

Buyer Products:

  • Promethazine Hydrochloride/Phenylephrine Hydrochloride
  • Phenergan VC (Promethazine Hydrochloride/Phenylephrine Hydrochloride)
  
Cardiovascular System  
Heart Disorders  
Angina  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat chest pains by inhibiting stimulation of beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Propranolol Hydrochloride
  • Atenolol
  
Arrhythmia  
Adenosine A1 Receptor Agonists
Therapeutics that treat abnormal rhythm of the heart beat by selectively stimulating the A1 adenosine receptor, slowing the speed of AV nodal conduction

Buyer Products:

  • Adenosine
  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat abnormal rhythm of the heart beat by inhibiting the stimulation of beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Baxter BioScience Brevibloc (Esmolol HCl)
  • Propranolol Hydrochloride
  • Acebutalol Hydrochloride
  
Potassium Channel Blocking Agents
Therapeutics that treat abnormal rhythm of the heart by preventing the entry of potassium into heart muscle cells.

Buyer Products:

  • Quinidine Sulfate ER
  
Heart Failure (HF)  
Complications  
Edema  
Loop Diuretic Agents
Therapeutics that treat the excessive accumulation of fluids by increasing the excretion of sodium, potassium, chloride ions, and water in urine.

Buyer Products:

  • Baxter Healthcare Bumetanide
  
Myocardial Infarction (MI)  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat irreversible damage to the heart muscle by blocking the beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Propranolol Hydrochloride
  • Atenolol
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of heart and circulatory system disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • CD34+ Cells (Adult Stem Cells)
  
Vascular Disorders  
Deep Vein Thrombosis (DVT)  
Anticoagulating Agents (Anticoagulants)  
Thrombin Inhibitors
Therapeutics that prevent or treat clots in blood vessels by preventing blood clots from forming.

Buyer Products:

  • Heparin Sodium
  
Hypertension  
Alpha Adrenergic Receptor Agonists
Therapeutics that treat high blood pressure by stimulating the alpha adrenergic receptors of the heart muscle.

Buyer Products:

  • Guanfacine
  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat high blood pressure by blocking the beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Propranolol Hydrochloride
  • Atenolol
  • Acebutalol Hydrochloride
  
Hypovolemia  
Plasma Volumizers  
Albumin-Based
Therapeutics based on plasma proteins that treat a decrease in circulating fluid (plasma) in the body by increasing plasma volume.

Buyer Products:

  • Baxter BioScience Flexbumin (Albumin)
  • Baxter BioScience Buminate (Albumin)
  
Thromboembolism  
Anticoagulating Agents (Anticoagulants)  
Platelet Aggregation Inhibitors  
Phosphodiesterase Inhibitors
Therapeutics that treat the obstruction of a blood vessel by preventing platelets from clumping together.

Buyer Products:

  • Dipyridamole
  
Thrombin Inhibitors
Therapeutics that treat the obstruction of a blood vessel by preventing blood clots from forming.

Buyer Products:

  • Heparin Sodium
  
Digestive System  
Gastrointestinal Tract Disorders  
Gastroesophageal Disorders  
Gastroesophageal Reflux Disease (GERD)  
Dopamine Receptor Blocking Agents
Therapeutics that treat Gastroesophageal Reflux Disease (GERD) by blocking dopamine receptor and stimulating gastrointestinal movement without stimulating secretions from the pancreas, stomach or gall bladder.

Buyer Products:

  • Metoclopramide Hydrochloride
  
Nausea/Vomiting  
Serotonin Receptor Antagonists
Therapeutics that treat nausea and vomiting by blocking the serotonin receptors.

Buyer Products:

  • Ondansetron Injection
  • Granisetron Hydrochloride
  
Endocrinology/Metabolism  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of endocrinology disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • PROMAXX Microsphere Dry Powder Inhaled Insulin
  
Hematology  
Hemophilia  
Hemophilia A  
Clotting Agents
Therapeutics that aid in blood coagulation.

Buyer Products:

  • Baxter BioScience FEIBA VH (Immuno Anti-Inhibitor Coagulant Complex)
  • Baxter BioScience Advate/Ultra-High Dosage ADVATE (Antihemophilic Factor VIII, Plasma/Albumin Free Method (rAHF-PFM))
  • Baxter BioScience Hemofil M (Antihemophilic Factor (Human))
  
Hemophilia B  
Clotting Agents
Therapeutics that assist in blood coagulation.

Buyer Products:

  • Baxter BioScience FEIBA VH (Immuno Anti-Inhibitor Coagulant Complex)
  • Baxter BioScience Proplex T (Factor IX Complex)
  
Red Blood Cell (RBC) Disorders  
Anemia  
Recombinant Human Erythropoietins
Therapeutics that treat conditions characterized by reduced delivery of oxygen to body tissues by stimulating red blood cell production.

Buyer Products:

  • Baxter BioScience Epoetin Omega
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of hematological disorders in very early stages of research where no human subject is involved.

Buyer Products:

  • Long-Acting Recombinant Factor IX
  • Recombinant Protein ADAMTS13
  • AV513 (Non-Anticoagulant Sulfated Polysaccharide)
  • Baxter Healthcare Recombinant Factor VIII (Von Willebrand Factor (VWF)) Therapeutic Progarm
  
Serum Factor Disorders  
Hypoalbuminemia  
Albumin-Based
Therapeutics based on plasma proteins that treat low levels of serum albumin.

Buyer Products:

  • Baxter BioScience Flexbumin (Albumin)
  • Baxter BioScience Buminate (Albumin)
  • Baxter BioScience Albumin
  
Immunology  
Autoimmune Disorders  
Arthritis  
Rheumatoid Arthritis (RA)  
Analgesics  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by blocking cyclooxygenase activity.

Buyer Products:

  • Etodolac
  
Idiopathic Thrombocytopenia Purpura (ITP)  
Immunoglobulins
Therapeutics that treat a decrease in platelets by neutralizing autoantibodies with therapeutic antibodies.

Buyer Products:

  • Baxter BioScience WinRho SDF (Rho Immunoglobulin Lyophilized/Liquid Form)
  • Baxter BioScience IVEEGAM EN/Gamimune N (Immune Globulin)
  • Baxter BioScience IVEEGAM (Immune Globulin)
  • Baxter BioScience Gammagard S/D (Immune Globulin Intravenous Solvent/Detergent)
  
Kawasaki Syndrome  
Immunoglobulins
Therapeutics that treat Kawasaki Syndrome by neutralizing autoantibodies with therapeutic antibodies.

Buyer Products:

  • Baxter BioScience IVEEGAM EN/Gamimune N (Immune Globulin)
  • Baxter BioScience IVEEGAM (Immune Globulin)
  • Baxter BioScience Gammagard S/D (Immune Globulin Intravenous Solvent/Detergent)
  
Immune Deficiency Disorders  
Primary Immunodeficiency Diseases  
Immunoglobulins
Therapeutics that treat primary immunodeficiency diseases by providing the body with therapeutic antibodies.

Buyer Products:

  • Baxter BioScience GAMMAGARD Liquid 10% (Immune Globulin Intravenous Human)
  • Baxter BioScience Gammagard S/D (Immune Globulin Intravenous Solvent/Detergent)
  
Immunoglobulins/Hyaluronic Acid
Therapeutics that treat primary immunodeficiency diseases by providing therapeutic antibodies administered simultaneously with hyaluronic acid.

Buyer Products:

  • GAMMAGARD/rHuPH20 (Immune Globulin/Human Hyaluronidase Enzyme)
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of immune disorders in very early stages of research where no human subject is involved.

Buyer Products:

  • Recombinant ADAMTS13
  
Infectious Diseases  
Bacterial  
Antibacterial Agents  
Broad Spectrum  
Antibiotics  
Aminoglycosides
Therapeutics that treat a wide variety of infections by inhibiting bacterial protein synthesis.

Buyer Products:

  • Gentamicin Surgical Implant
  
Cephalosporin Derivatives
Therapeutics that treat a wide variety of infections by inhibiting bacterial cell wall synthesis.

Buyer Products:

  • Baxter Healthcare Cefepime
  • Ceftriaxone Sodium
  
Penicillin Derivatives
Therapeutics that treat a wide variety of infections by inhibiting bacterial cell wall synthesis during active multiplication.

Buyer Products:

  • Bactocill
  
Quinolones/Fluoroquinolones
Therapeutics that treat a wide variety of infections by promoting breakage of bacterial DNA strands.

Buyer Products:

  • Baxter Healthcare Ciprofloxacin In Dextrose Solution
  
Tetracyclines
Therapeutics that treat a wide variety of infections by inhibiting protein synthesis and also causing alterations in cytoplasmic membranes.

Buyer Products:

  • Minocycline Hydrochloride
  
Narrow Spectrum  
Respiratory System  
Bronchitis  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections leading to inflammation of the bronchi in the lungs by inhibiting certain enzymes that are vital for bacterial DNA transcription and repair.

Buyer Products:

  • Sulfamethoxazole/Trimethoprim
  
Pneumonia  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat inflammation of the lungs caused by bacterial infection by inhibiting folic acid synthesis and bacterial growth.

Buyer Products:

  • Sulfamethoxazole/Trimethoprim
  
Tuberculosis  
Antitubercular Agents
Therapeutics that treat a bacterial infection of the lung by inhibiting bacterial and mycobacterial RNA synthesis.

Buyer Products:

  • Pyrazinamide
  
Urology  
Urinary Tract Infections (UTI)  
Antibacterial Agents (Antibiotics)  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections of the urinary tract by inhibiting dihydrofolate reductase resulting in decreased bacterial nucleic acid/protein production.

Buyer Products:

  • Sulfamethoxazole/Trimethoprim
  
Vaccines  
Bacterial  
Combination  
Diphtheria/Tetanus/Acellular Pertussis (DTaP)
Therapeutics that prevent or treat infectious disease by producing or artificially increasing immunity to pathogens that cause diphtheria, tetanus, and acellular pertussis.

Buyer Products:

  • Baxter BioScience Certiva (DTaP)
  
Mycological (Fungal)  
Antifungal Agents  
Narrow Spectrum  
Dermatology  
Tinea Barbae  
Penicillin Derivatives
Therapeutics that treat fungal infections of the bearded area by inhibiting the biosynthesis of cell walls.

Buyer Products:

  • Griseofulvin
  
Tinea Capitis  
Penicillin Derivatives
Therapeutics that treat fungal infections of the scalp by inhibiting biosynthesis of cell walls.

Buyer Products:

  • Griseofulvin
  
Tinea Corporis (Ringworm)  
Penicillin Derivatives
Therapeutics that treat fungal infections of the skin characterized by scaly, red rings by inhibiting the biosynthesis of cell walls.

Buyer Products:

  • Griseofulvin
  
Tinea Cruris (Jock Itch)  
Penicillin Derivatives
Therapeutics that treat fungal infections of the groin and perineum by inhibiting the biosynthesis of cell walls.

Buyer Products:

  • Griseofulvin
  
Tinea Pedis  
Penicillin Derivatives
Therapeutics that treat fungal infections of the feet by inhibiting the biosynthesis of cell walls.

Buyer Products:

  • Griseofulvin
  
Tinea Unquium  
Penicillin Derivatives
Therapeutics that treat fungal infections of the nails by inhibiting the biosynthesis of cell walls.

Buyer Products:

  • Griseofulvin
  
Tinea Versicolor  
Penicillin Derivatives
Therapeutics that treat fungal infections of skin exposed to the sun characterized by patches of depigmentation by inhibiting the biosynthesis of cell walls.

Buyer Products:

  • Griseofulvin
  
Nervous System  
Cryptococcal Meningitis  
Triazoles
Therapeutics that treat fungal infections of lining of the brain and the spinal cord by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.

Buyer Products:

  • Fluconazole
  
Otolaryngology (Ear/Nose/Throat)  
Esophageal Candidiasis  
Triazoles
Therapeutics that treat fungal infections of the esophagus caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.

Buyer Products:

  • Fluconazole
  
Oropharyngeal Candidiasis  
Azoles  
Triazoles
Therapeutics that treat fungal infections of the mouth and pharynx caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.

Buyer Products:

  • Fluconazole
  
Urology  
Vaginal Candidiasis  
Azoles  
Triazoles
Therapeutics that treat fungal infections of the female reproductive organ caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.

Buyer Products:

  • Fluconazole
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of infectious diseases in early stages of clinical research where human subject is involved.

Buyer Products:

  • Baxter Bioscience Vero Seasonal Influenza Vaccine
  • Baxter BioScience Haemophilus Influenzae Type B Vaccine
  • H5N1 Pandemic Influenza Vaccine
  • Baxter BioScience Acellular Pertussis (aP) Vaccine
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of infectious diseases in very early stages of research where no human subject is involved.

Buyer Products:

  • Baxter BioScience Escherichia coli Vaccine
  
Viral  
DNA Viruses  
Herpesvirus  
Herpes Simplex Type 1  
Purine Nucleoside Analogs
Therapeutics that treat viral infections characterized by recurrent cold sores and fever blisters by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Buyer Products:

  • Acyclovir
  
Herpes Simplex Type 2  
Purine Nucleoside Analogs
Therapeutics that treat viral infections characterized by recurring outbreaks of painful genital lesions by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Buyer Products:

  • Acyclovir
  
Varicella Zoster  
Herpes Zoster (Shingles)  
Purine Nucleoside Analogs
Therapeutics that treat viral infections that cause shingles in adults by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Buyer Products:

  • Acyclovir
  
Varicella (Chickenpox)  
Purine Nucleoside Analogs
Therapeutics that treat viral infections that cause chicken pox in children by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Buyer Products:

  • Acyclovir
  
Vaccines  
Viral  
Single Target  
Influenza (Flu)
Therapeutics that prevent or treat viral infections of the respiratory tract by producing or artificially increasing immunity to the Influenza virus.

Buyer Products:

  • Baxter Bioscience Vero Seasonal Influenza Vaccine
  
Musculoskeletal System  
Skeletal Disorders  
Joint Disorders  
Osteoarthritis (OA)  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat inflammation by non-specifically inhibiting the action of cyclooxygenase.

Buyer Products:

  • Etodolac
  
Rheumatoid Arthritis (RA)  
Analgesics  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by blocking cyclooxygenase activity.

Buyer Products:

  • Etodolac
  
Neurology  
Neurological Disorders  
Alzheimer`s Disease  
Immunoglobulins
Therapeutics that treat and manage Alzheimer's disease by providing a therapeutic protein.

Buyer Products:

  • Baxter BioScience GAMMAGARD Liquid 10% (Immune Globulin Intravenous Human)
  
Epilepsy  
Status Epilepticus  
Sodium Channel Modulators
Therapeutics that treat Status Epilepticus by modulating the portal that allows sodium into the nerve cells.

Buyer Products:

  • Fosphenytoin Sodium
  
Headaches  
Vascular (Migraine)  
Prophylactic Treatments  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat Migraine by inhibiting stimulation of beta adrenergic receptors.

Buyer Products:

  • Propranolol Hydrochloride
  
Neuromuscular Disorders  
Myasthenia Gravis (MG)  
Cholinesterase Inhibitors
Therapeutics that treat Myasthenia Gravis by maintaining the transmission of nerve impulses by inhibiting the enzyme that breaks down acetylcholine.

Buyer Products:

  • Baxter BioScience Enlon-Plus(R) (Edrophonium Chloride, USP & Atropine Sulfate, USP)
  • Baxter BioScience Enlon(R) (Edrophonium Chloride, USP)
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of nervous system and mental disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • Baxter BioScience GAMMAGARD Liquid 10% (Immune Globulin Intravenous Human)
  
Psychiatric Disorders  
Anxiety  
Generalized Anxiety Disorder (GAD)  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat anxiety by enhancing the inhibitory neurotransmitter action of gamma-aminobutyric acid.

Buyer Products:

  • Lorazepam
  • Diazepam
  
Sleep Disorders  
Insomnia  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat insomnia by enhancing the inhibitory action of gamma-aminobutyric acid.

Buyer Products:

  • Diazepam
  
Oncology  
Breast Cancer  
Localized  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage breast cancers by interacting with DNA and inhibiting cell division.

Buyer Products:

  • Cyclophosphamide Injection
  
Hematology  
Leukemia (White Blood Cell Cancer)  
Lymphoid  
Acute  
Lymphoblastic  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage rapidly progressing cancers of immature lymphocytic cells by interacting with DNA and inhibiting cell division.

Buyer Products:

  • Cyclophosphamide Injection
  
Lymphocytic  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage rapidly progressing cancers of lymphocytic cells by interacting with DNA and inhibiting cell division.

Buyer Products:

  • Cyclophosphamide Injection
  
Chronic  
Lymphocytic (CLL)  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage slowly progressing cancers of lymphocytic cells by interacting with DNA and inhibiting cell division.

Buyer Products:

  • Cyclophosphamide Injection
  
Immunoglobulins
Therapeutics that treat and manage slowly progressing cancers of lymphocytic cells by providing a therapeutic protein.

Buyer Products:

  • Baxter BioScience Gammagard S/D (Immune Globulin Intravenous Solvent/Detergent)
  
Myeloid  
Acute  
Monocytic  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage cancers of mononuclear cells by interacting with DNA and inhibiting cell division.

Buyer Products:

  • Cyclophosphamide Injection
  
Myelogenous (AML)  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage rapidly progressing cancers of myelogenous cells by interacting with DNA and inhibiting cell division.

Buyer Products:

  • Cyclophosphamide Injection
  
Chronic  
Granulocytic  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage slowly progressing cancers of myelocytic cells by interacting with DNA and inhibiting cell division.

Buyer Products:

  • Cyclophosphamide Injection
  
Lymphoma (Lymphatic Cancer)  
Cutaneous T-Cell Lymphoma (CTCL)  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage T-Cell lymphomas of the skin by interacting with DNA and inhibiting cell division.

Buyer Products:

  • Cyclophosphamide Injection
  
Hodgkin`s Disease  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage lymphoma characterized by the presence of Reed-Sternberg cells by interacting with DNA and inhibiting cell division.

Buyer Products:

  • Cyclophosphamide Injection
  
Non-Hodgkin`s Lymphoma (NHL)  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage lymphomas of B-cells and T-cells by interacting with DNA and inhibiting cell division.

Buyer Products:

  • Cyclophosphamide Injection
  
Multiple Myeloma (Plasma Cell Cancer)  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage cancers of mature antibody producing white blood cells by interacting with DNA and inhibiting cell division.

Buyer Products:

  • Cyclophosphamide Injection
  
Neurology  
Brain Cancer  
Neuroblastoma  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage cancer of primitive ganglion cells by interacting with DNA and inhibiting cell division.

Buyer Products:

  • Cyclophosphamide Injection
  
Opthalmology  
Retinoblastoma  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage cancers of the retina by interacting with DNA and inhibiting cell division.

Buyer Products:

  • Cyclophosphamide Injection
  
Urology  
Ovarian Cancer  
Adenocarcinoma  
Alkylating Agents  
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage cancer of cells lining the ovary by interacting with DNA and inhibiting cell division.

Buyer Products:

  • Cyclophosphamide Injection
  
Pain Management  
Anesthesia  
General (Systemic)  
Adjunctive  
Acetylcholine Blocking Agents
Therapeutics that inhibit neuromuscular activity by competing with acetylcholine at the cholinergic receptors resulting in neuromuscular blockage.

Buyer Products:

  • Atracurium Besylate
  
Ether-Based Agents
Therapeutics that result in anesthesia due to interfering with the physiological functioning of nerve cell membranes in the brain.

Buyer Products:

  • Baxter BioScience Suprane(R) (Desflurane, USP)
  • Baxter BioScience Ethrane(R) (Enflurane, USP)
  • Baxter BioScience Forane(R) (IsoFlurane, USP)
  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that result in anesthesia by enhancing the inhibitory neurotransmitter action of gamma-aminobutyric acid.

Buyer Products:

  • Midazolam
  • Diazepam
  
Hypnotic Agents (Sedatives)
Therapeutics that result in anesthesia by inducing sleep. These therapeutics have no analgesic action.

Buyer Products:

  • Propofol
  
Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alters both the perception of pain as well as the emotional response to pain.

Buyer Products:

  • Meperidine HCl
  • Sufentanil Citrate
  • Morphine Sulfate
  
Reversal  
Gamma-Aminobutyric Acid (GABA) Receptor Antagonists
Therapeutics that reverse general anesthesia by competitively inhibiting benzodiapizines at the GABA receptors, thus reducing their effect and reversing the anesthesia.

Buyer Products:

  • Flumazenil
  
Narcotics  
Analgesics/Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alters the both the perception of pain as well as the emotional response to pain.

Buyer Products:

  • Hydrocodone Bitartrate/Acetaminophen
  
Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alter both the perception of pain as well as the emotional response to pain.

Buyer Products:

  • Sufentanil Citrate
  • Infumorph (Morphine Sulfate)
  • Morphine Sulfate
  
Non-Narcotics  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain by non-specifically inhibiting the action of cyclooxygenase.

Buyer Products:

  • Ketorolac Tromethamine
  • Etodolac
  
Skeletal Muscle Relaxing Agents
Therapeutics that treat pain by depressing specific synaptic reflexes preferentially.

Buyer Products:

  • Robaxin (Methocarbamol)
  
Respiratory System  
Lower Respiratory Tract Disorders (Lung Disorders)  
Bronchitis  
Complications  
Bacterial Infections  
Antibacterial Agents (Antibiotics)  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections by inhibiting certain enzymes that are vital for bacterial DNA transcription and repair.

Buyer Products:

  • Sulfamethoxazole/Trimethoprim
  
Emphysema  
Congenital  
Proteinase Inhibitors
Therapeutics that treat emphysema by providing certain proteins. The body's lack of ability to manufacture these proteins results in the disease state.

Buyer Products:

  • Glassia (Alpha-1 Proteinase Inhibitor)
  • Baxter Biosciences Aralast (Alpha-1 Proteinase Inhibitor)
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of respiratory disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • Recombinant Alpha 1-Antitrypsin (AAT) Therapy
  
Upper Respiratory Tract Disorders  
Coughs/Colds  
Antihistamines
Therapeutics that inhibit the inflammation by blocking the action of histamines on tissues.

Buyer Products:

  • Phenergan (Promethazine)
  • Diphenhydramine
  
Antihistamines/Antitussives
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.

Buyer Products:

  • Promethazine Hydrochloride/Dextromethorphan Hydrochloride
  • Phenergan With Dextromethorphan (Promethazine Hydrochloride/Dextromethorphan Hydrochloride)
  
Antihistamines/Decongestants
Therapeutics that block the inflammatory action of histamines and reduces the amount of mucous build up.

Buyer Products:

  • Promethazine Hydrochloride/Phenylephrine Hydrochloride
  • Phenergan VC (Promethazine Hydrochloride/Phenylephrine Hydrochloride)
  
Antihistamines/Decongestants/Opioids
Therapeutics that treat coughs and colds by suppressing histamine-related inflammation, preventing congestion and altering both the perception and emotional response to pain.

Buyer Products:

  • Phenergan VC With Codeine (Promethazine Hydrochloride/Phenylephrine Hydrochloride/Codeine Phosphate)
  
Antihistamines/Opioids
Therapeutics that treat coughs and colds by suppressing histamine-related inflammation and altering both the perception and emotional response to pain.

Buyer Products:

  • Phenergan With Codeine (Promethazine HCL/Codeine Phosphate)
  
Surgery  
Cardiovascular System  
Thrombosis  
Thrombin Inhibitors
Therapeutics that thin the blood of a blocked blood vessel during surgery by blocking an enzyme involved in the clotting process.

Buyer Products:

  • Heparin Sodium
  
General  
Complications  
Hemorrhage  
Fibrinolysis Inhibitors
Therapeutics that treat complications involving bleeding after surgical procedures by inhibiting the breakdown of fibrin in blood clots.

Buyer Products:

  • Baxter BioScience Tisseel VH Kit (Two-Component Fibrin Sealant)
  
Thrombosis  
Anticoagulating Agents (Anticoagulants)  
Thrombin Inhibitors
Therapeutics used to control and treat blood clots by preventing the action of thrombin, a key enzyme involved in the clot formation process.

Buyer Products:

  • Heparin Sodium
  
Musculoskeletal System  
Deep Vein Thrombosis (DVT)  
Anticoagulating Agents (Anticoagulants)  
Thrombin Inhibitors
Therapeutics that treat vascular obstructions due to platelets and cell matter by blocking an enzyme involved in the clotting process.

Buyer Products:

  • Heparin Sodium
  
Neurology  
Seizures  
Sodium Channel Modulators
Therapeutics that treat seizures by controlling the entrance of sodium into the nerve cells.

Buyer Products:

  • Fosphenytoin Sodium
  
Toxicology  
Substance Abuse  
Withdrawal  
Alcohol  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat alcohol withdrawal by increasing the effect of GABA at the relevant neuroreceptors.

Buyer Products:

  • Diazepam
  
Urology  
Urological Disorders  
Bladder  
Cystitis  
Urotoxin Neutralizing Agents
Therapeutics that inhibit cystis induced by toxic therapeutics by neutralizing these therapeutics.

Buyer Products:

  • Mesnex (Mesna)
  
Healthcare Services  
Patient Care  
Ambulatory/Outpatient  
Specialized  
Dialysis Services
The process of cleansing the blood of end stage renal disease patients (ESRD) through the use of a semipermeable membrane, which allows waste products to pass but retains most of the blood's normal constituents. Dialysis services can be provided in outpatient settings, in patients' home, or in hospitals as a contractor.

Buyer Products:

  • RMS Lifeline
  • RMS Disease Management
  • Baxter Renal Care
  
Medical Devices
Anesthesiology  
Diagnostic  
Monitoring  
Systems  
Consciousness Monitoring
Systems designed to monitor the effect of anesthesia on patients during surgery.

Buyer Products:

  • Physiometrix Patient State Analyzer (PSA) 4000
  
Surgical  
General Procedure  
Delivery Systems  
Gas  
Breathing Accessories
Ancillary devices used to aid the administering of inhaled anesthetics, such as breathing bags and breathing masks.

Buyer Products:

  • Baxter Breathing Bag Series
  • Ultra-Fit Anesthesia Face Mask Series
  
Breathing Circuits
Devices which assist in physical mechanism of breathing.

Buyer Products:

  • Baxter Renal Care
  • Baxter Isoflex Series Breathing Circuits
  
Percutaneous (Subcutaneous/Intramuscular/Intravenous)  
Fluid Administration Sets
Intravenous fluid administration sets used to deliver anesthesia.

Buyer Products:

  • Auto Syringe Pump Set Series
  
Pumps/Systems
Devices used to pump intravenous fluids at a consistent programmed rate.

Buyer Products:

  • Auto Syringe Pump Set Series
  
Viscoelastics
Materials that can be applied to the skin and decrease resistance of to injected drugs.

Buyer Products:

  • Hylenex (Recombinant Human Hyaluronidase)
  
Procedure/Region Specific  
Delivery Systems  
Epidural
Devices used to inject anesthetic into the epidural space to numb the legs and abdomen, which include catheters, needles, syringes and other prepackaged kits.

Buyer Products:

  • Single-Pack Epidural Needle Series
  • Continuous Double-Deck Epidural Anesthesia Tray Series
  
Nerve Block
Devices used to assist in the delivery of nerve block anesthetic, which include catheters, needles and other prepackaged kits.

Buyer Products:

  • Single-Deck Nerve Block Tray Series
  
Spinal
Devices used to inject anesthetic into the spine, which include catheters, needles and other prepackaged kits.

Buyer Products:

  • Single-Pack Epidural Needle Series
  • Continuous Double-Deck Epidural Anesthesia Tray Series
  
Cardiology  
Surgical  
General Procedure  
Accessories  
Vessel Closure
Devices used to close heart blood vessels.

Buyer Products:

  • Fusion Medical FloSeal FAST
  
Clinical Diagnostics  
Specimen Collection  
Blood  
Capillary  
Lancets
Sharps type of device used to puncture the skin in order to collect a capillary blood sample.

Target Products:

  • Hawaii Medical NeatNick Lancet
  
Drug Delivery  
Infusion Therapy  
Accessories  
Admixture Systems
Medical systems designed to combine multiple medications for delivery to the patients

Buyer Products:

  • Clintec Automix(R) Compounder System and Accessory
  
Closed Blood Sampling Systems
Sampling systems which do not use needles to access infusion systems to obtain a blood sample.

Buyer Products:

  • Edwards VAMP
  
Filtration Products
Device used to filter fluids for infusion.

Buyer Products:

  • I.V. Filtration Set Series
  • Fenwal Blood Device And Set Series
  
Fluid Administration/Extension Sets
Filtered IV sets designed for infusion therapy.

Buyer Products:

  • Needle*Lock(TM) Device and Set Series
  • High Flow Rate Extension Set
  
Fluid Warmers
Medical devices used to maintain the warmth of the medical products prior to and during the infusion process.

Buyer Products:

  • ThermaCyl Blood/Fluid Warmer
  
Needleless Fluid Administration/Extension Sets
Valve systems designed to work without needles to prevent patient injuries.

Buyer Products:

  • Clearlink
  • Baxject Needleless Transfer Device
  
Pump Sets
Pump sets designed specifically for infusion therapy.

Buyer Products:

  • Auto Syringe Pump Set Series
  
Delivery Systems  
Elastomeric Infusors
Infusion delivery system designed for small-volume fluid transmission (home use).

Buyer Products:

  • Intermate Infusor System Series
  
Pumps  
Multiple Channel
Multiple channel pump designed to deliver more than one infusion therapy to patients.

Buyer Products:

  • COLLEAGUE Infusion Pump
  • Auto Syringe Pump Set Series
  
Single Channel
Single channel pump designed to deliver only one infusion therapy to patients.

Buyer Products:

  • Auto Syringe Pump Set Series
  
Syringe
Syringe used in place of a pump to deliver infusion therapy.

Buyer Products:

  • Syndeo PCA Syringe Pump
  • Auto Syringe Pump Set Series
  
Integrated/Comprehensive Systems
Complete infusion systems that include pumps, monitoring devices and other accessories.

Buyer Products:

  • Ipump Pain Management System
  
Vascular Access  
Peripheral Intravenous Catheters  
Infusion Sets
Complete infusion sets containing peripheral intravenous catheters.

Buyer Products:

  • Sub-Q-Set Subcutaneous Series
  • Micro-Volume Series
  
Standard
Non-ported peripheral intravenous catheters.

Buyer Products:

  • Interlink Flash-Cath Series
  
Ear/Nose/Throat (ENT)  
Diagnostic  
Physical Examination  
Ear  
Auditory Tests  
Auditory Evoked Potential (AEP)
Devices used to test the brain's response to auditory stimulation.

Target Products:

  • Sonamed Clarity Screener
  • Centor
  • HINT Pro Hearing in Noise Test
  • Bio-logic Systems Stacked ABR
  • ALGO 3/3i Newborn Hearing Screener
  • Bio-logic Systems CHAMP
  • Bio-logic Systems Ears Muffin/Halo Ear Muffin
  • Bio-Logic Navigator Pro
  • ABaer Newborn Hearing Screener
  
Otoacoustic Emission (OAE)
Devices used to measure tones that originate in the cochlea.

Target Products:

  • Natus Echo-Screen
  • Coclea-Scan
  • Sonamed Clarity Screener
  • Bio-Logic Scout Sport
  • AuDX Pro
  
Instruments
Instruments used to inspect the ear or a patient's hearing, such as speculums and tuning forks.

Target Products:

  • NeuroCom Balance Manager System
  • NeuroCom Equitest
  
Gastroenterology  
Treatment  
Stomach  
Tubes  
Feeding
A tube that carries food to the stomach.

Buyer Products:

  • Clintec Dual Port Feeding Tube Series
  
General Surgery  
Invasive  
Surgical-Site Treatments  
Anti-Adhesives/Anti-Scarring  
Gels
Gel-based products applied during interventional procedures to prevent adhesion to medical devices or to prevent scarring of the surgical site

Buyer Products:

  • ADEPT Adhesion Reduction Solution
  
Sealants  
Adhesives
Glue based products used to seal tissue during surgical procedures

Buyer Products:

  • ARTISS (Human Fibrin Sealant)
  
Hemostatic  
Delivery Systems
Medical devices designed to deliver hemostatic sealants to the surgical site

Buyer Products:

  • Tissomat Application Device
  
Sponges
Microfibrillar sponge used when conventional hemostasis procedures are not effective.

Buyer Products:

  • Fusion Medical FloSeal Sponge
  
Topical
Topical mixture used when conventional hemostasis procedures are not effective.

Buyer Products:

  • TachoSil (Fibrin Sealant Patch)
  • Baxter BioScience Tisseel VH Kit (Two-Component Fibrin Sealant)
  • Fusion Medical FloSeal Matrix
  
Medical Supplies
Diagnostic
Clinical Examination
Basic Examining Tools
Medical instruments used to examine and monitor basic physiological functions, such as reflex, blood pressure, heart rate, and pulmonary capacity. These instruments include stethoscopes, sphygmomanometers, percussion hammers and other similar items.

Buyer Products:

  • French Esophageal Stethoscope Series

Target Products:

  • Olympic Trans-Lites Transilluminator Series
Furnishings  
Bedroom and Bath  
Patient Care Accessories/Furniture
Furniture and accessories designed for hospital patients, such as beds, bed rails, linens, overbed tables, nurse call systems, carts, and other related items.

Target Products:

  • Shell-O Gel Pillow and Positioning Aid/StarBaby
  • LilyPad Pressure Relieving Memory Foam
  
Safety and Sterilization
Safety
Patient Protection
Medical clothing and protective gear designed to provide protection and comfort to patients.

Target Products:

  • Natus Pediatric & Newborn Care Products
  • Natus Save The Gonads
  
Waste Management
Products used to control and contain biohazardous materials, such as chemical waste, fluid waste, and solid waste. These products may include bags, containers, and other more advanced waste treatment systems.

Buyer Products:

  • Bentley BosPac Plus
  
Sterilization  
Systems
Cleaning systems that use chemicals, steam and other sanitary methods to sterilize medical products and supplies.

Target Products:

  • Olympic Sterile-Driers
  • Olympic Pasteurmatic/Pasteurmatic Compact/Mini-Pateurmatic Systems
  
Surgical  
Surgical Supplies/Tools
Devices used to aid or perform surgical functions such surgical lights, surgical markers, surgical table, positioners, towels, stockinette, sanitation agents, and other similar items.

Target Products:

  • Suture Ring
  • Olympic Vac-Pac
  
Treatment  
Wound Management  
Cleaning/Healing Devices
Devices used to clean and facilitate healing of wounds, such as bandages, dressings, cleansers, anti-infective ointments, sponges, cold compresses and other similar items.

Buyer Products:

  • GELFOAM Plus Hemostasis Kit (Human Thrombin Sponge)
  
Neonatology  
Diagnostic  
Monitoring  
Accessories  
Electrocardiogram (ECG/EKG) Electrodes
Devices that act as sensors for the electrical signals of the newborn's heart.

Target Products:

  • LifeGuard ECG STAT Pad
  
Treatment  
Phototherapy
A device that uses ultraviolet light to help the body break down bilirubin in the blood of a newborn.

Target Products:

  • Bili-Meter
  • Bili-Lites
  • Bili-Bassinet
  • neoBLUE/neoBLUE mini/neoBLUE cozy LED Phototherapy Systems
  • Medix I.C.S.A - MediLED Phototherapy Lamp
  
Protective Devices
Devices used to prevent injury to the baby, including their eyes, ears, septum and other body parts.

Target Products:

  • MiniMuffs Neonatal Noise Attenuator
  • Natus Neonatal Oxygen Hoods
  • Circumstraint
  • Bili-Masks
  
Temperature Control
Devices that provide temperature management around a newborn, including warmers, incubators, incubator humidifiers, oxygen hoods and other similar items.

Target Products:

  • Natus Neonatal Oxygen Hoods
  • Medix I.C.S.A - Natal Care ST-MX/LX/BX Intensive Care Incubators
  • SunFish Temperature Probe Cover/Essentials Temperature Probes
  • Olympic Cool-Cap
  • Medix I.C.S.A - Infant Warmer
  
Neurology
Diagnostic
Monitoring
Accessories  
Stimulators
Probes that send electricity to excitable tissues, such as brain tissue , where brain functionality is mapped according to the response received after stimulation.

Target Products:

  • Bio-Logic Netlink Amplifiers
  
Transducers
Devices used to convert physiological events into electrical signals for display and/or further analysis.

Target Products:

  • Schwarzer comlab Series Digital Polysomnography Acquisition System
  
Monitors
Electroencephalograph (EEG)
General
An electroencephalograph that is used for any examination purpose.

Target Products:

  • Kortex
  • Deltamed Coherence Routine/Mobile/Portable EEG Series
  • BrainZ BRM3
  • Vitaport 3 EEG/Polysomnography System
  • EPAS Series EEG/Polysomnography Systems
  • Bio-Logic Ceegraph VISION ICU
  • Bio-Logic Ceegraph VISION
  • Olympic CFM 6000
  • Excel-Tech Trex Home EEG/PSG
  • xltech EMU40/EMU128FS
  • xltech EEG32U
  • xltech ICU Brain Monitor
  • EEG Signal Amplifiers
  
Intraoperative
An electroencephalograph that is used during surgery.

Buyer Products:

  • Physiometrix Patient State Analyzer (PSA) 4000

Target Products:

  • xltech Protektor IOM
Polysomnography
Devices that simultaneously and continuously monitor relevant normal and abnormal physiological activity during sleep.

Target Products:

  • Xltek PSG
  • Deltamed Coherence PSG-plus unit
  • Vitaport 3 EEG/Polysomnography System
  • Excel-Tech Trex Home EEG/PSG
  • xltech Connex Polysomnography
  • Excel-Tech Trex Home Sleep
  • Bio-Logic Sleepscan Vision
  • EPAS Series EEG/Polysomnography Systems
  
Electromyograph (EMG)
A device used to measure the electrical activity of muscle.

Target Products:

  • xltech Xcalibur EMG
  • EMG Posturography System
  • xltech NeuroMax EMG
  
Epilepsy
A neurological disorder caused by disturbances of the electrical activity of the brain characterized by seizure or spasms.

Target Products:

  • Bio-Logic Ceegraph LTM
  
Neuromuscular Transmission (NMT)
A device used to measure electrical signal from the brain that control muscles.

Target Products:

  • mags 1/2 Magnetic Stimulator
  
Surgical  
General Procedure  
Surgical Sealants
A glue like material, made up of biomaterials, that is used to close up surgical incisions.

Buyer Products:

  • Fusion Medical Proceed
  
Ophthalmology  
Surgical  
Procedure/Region Specific  
Cataract  
Viscoelastics
Material that can be applied to decrease resistance between two parts of the eye and promote healing and repair of damaged eye tissue.

Buyer Products:

  • Hylenex (Recombinant Human Hyaluronidase)
  
Orthopedics  
Surgical  
Procedure Specific  
Bone Loss Reconstruction  
General  
Bone Fillers
Devices used to fill the formed bone cavity with hardening material.

Buyer Products:

  • Actifuse
  • Tricos T Bone Void Filler
  
Respiratory
Treatment
Assisted Breathing
Intubation
Accessories
Accessories for instrumentation that is inserted into the trachea.

Target Products:

  • Olympic Endo-Lok
  • Olympic Trach-Button Tracheostomy Button
  • Bio-logic Systems Ears Muffin/Halo Ear Muffin
  
Breathing Circuits
Instrument used to measure respiratory parameters such as pressure.

Buyer Products:

  • Baxter Isoflex Series Breathing Circuits
  
Positive Airway Pressure (PAP)  
Accessories
Instruments used to maintain/regain positive airway pressure.

Target Products:

  • Hawaii Medical CookieCap
  
Transfusion Medicine  
Blood Collection  
Accessories  
Collection/Storage
Devices, usually polymer plastic bags used for collection and subsequent storage of blood and blood components. Specific additives may or may not be incorporated to prevent the collected blood from clotting.

Buyer Products:

  • Cryocyte Freezing Containers
  
Apheresis Systems  
Plasma
Systems which separate and collect the plasma component of human blood while returning other blood components to the donor.

Buyer Products:

  • Fenwal Amicus
  
Platelets
Systems which separate and collect the platelet cell component of human blood while returning other blood components to the donor.

Buyer Products:

  • Fenwal Amicus
  
Red Blood Cells
Systems which separate and collect the red cell component of human blood while returning other blood components to the donor.

Buyer Products:

  • Fenwal Amicus
  
Blood Washers
Instruments used to wash blood cells in preparation for usage; they are often used to prepare frozen red blood cells for transfusion.

Buyer Products:

  • Cytomate Cell Processing System
  
Filtration Systems
Medical devices used to filter leukocytes from blood during the transfusion process.

Buyer Products:

  • Sepacell RZ-2000
  • Sepacell Leukocyte Reduction Filters
  
Viral Inactivation  
Plasma
Medical devices and technology which destroy infectious agents such as viruses in donor plasma without damaging the integrity of the plasma proteins.

Buyer Products:

  • Helinx Intercept Plasma System
  
Platelets
Medical devices and technology which destroy infectious agents such as viruses in blood products (platelets) without damaging the integrity of the donor platelet cells.

Buyer Products:

  • Helinx Intercept Platelet System
  
Red Blood Cells
Medical devices and technology which destroy infectious agents such as viruses in donor blood without damaging the integrity of the donor red blood cells.

Buyer Products:

  • Helinx Intercept Red Blood Cell System
  
Urology  
Surgical  
General Procedure  
Minimally Invasive/Cystoscopy  
Irrigation Pumps/Systems
Surgical instruments that pump fluids to irrigate/moisten the surface of the urinary organs

Buyer Products:

  • Irrigation Set Series
  
Treatment  
Renal  
Hemodialysis  
Components  
Concentrates
Chemicals used in hemodialysis.

Buyer Products:

  • Althin Biopharm
  
Dialysate Parameter Monitors
Medical products used to monitor parameters such as fluid pressure, concentration, pH etc. during dialysis procedures.

Buyer Products:

  • Althin Biopharm Hemavision
  
Filtration  
Dialyzers
The instrument or medium used to effect chemical dialysis which allows for the diffusion of waste products and excess water into a dialysate solution.

Buyer Products:

  • Althin Altra Flux
  
Hemofilters
Filters used to separate the blood from the waste components during dialysis through a convection process by creating negative pressure to draw out solute particles without using a dialysate solution.

Buyer Products:

  • Renalflo II
  
Systems
A complete set of devices that act as a kidney to remove waste from the circulatory system.

Buyer Products:

  • Althin AltraTouch 1000
  
Peritoneal Dialysis  
Components  
Solutions
Chemical agents used in peritoneal dialysis.

Buyer Products:

  • Extraneal (Icodextrin)
  • Dianeal Series
  
Systems  
Automated Peritoneal Dialysis (APD)
Complete set of instruments and devices that cycle solution to and from the patient's peritoneum during sleep.

Buyer Products:

  • HomeChoice Automated
  
Continuous Ambulatory (CAPD)
Complete set of instruments and devices that perform peritoneal dialysis that can be moved around with the patient.

Buyer Products:

  • UltraBag System
  
Vascular  
Surgical  
General Procedure  
Accessories  
Introducers
Devices used to provide percutaneous introduction of catheters, interventional devices, and temporary pacing leads into the vasculature.

Buyer Products:

  • V-Link Luer-Activated Device (LAD)
  
Vessel Closure
Devices used to close and repair vascular structures, including both complete systems and associated clamps, felts and pledgets.

Buyer Products:

  • Fusion Medical FloSeal FAST
  
Nutritional Health  
Dietary/Naturopathic Supplements  
General Health
Products consisting of dietary/naturopathic supplements that are intended to support general health.

Buyer Products:

  • Baxter Inernational Inc.
  
Outsourced Biomedical Services  
Development/Manufacturing Services  
Contract Manufacturing Organizations (CMO)  
Biopharmaceutical OEM  
Final Dosage Forms
Contract Manufacturing Organizations (CMO) that produce large quantities of drug products in final dosage forms ready to be sold to end users.

Buyer Products:

  • Baxter Bioscience
  

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Relationship Details

Key Competitors

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  Genzyme Corporation n/a 18,538.576 n/a 56.13 4.66 4.30 4.90
Fresenius Medical Care AG & Co. (ADR) n/a 16,611.058 17.42 17.40 1.39 1.39 n/a
Hospira, Inc. n/a 9,229.383 23.47 16.08 2.32 2.35 8.62
Talecris Biotherapeutics Holdings Corp n/a 2,982.982 9.93 14.92 1.89 1.86 5.09
Crucell N.V. (ADR) n/a 2,701.573 n/a -93.46 5.74 5.59 3.08
Moog Inc. n/a 1,951.477 18.05 n/a 0.92 n/a 9.28
NxStage Medical, Inc. n/a 1,187.135 n/a -35.85 6.98 6.80 136.39
ICU Medical, Incorporated n/a 500.586 17.64 18.08 1.80 1.80 2.04
Akorn, Inc. n/a 492.571 n/a 60.22 6.12 6.07 8.41
Omnicell, Inc. n/a 457.628 95.82 81.94 2.08 2.07 2.01
BioTime, Inc. n/a 390.764 n/a n/a 129.77 n/a 17.03
Cytori Therapeutics Inc. (USA) n/a 272.750 n/a -9.24 24.87 26.64 2,147.63
Nymox Pharmaceutical Corporation n/a 227.622 n/a -37.85 415.38 n/a n/a
YM BioSciences Inc. (USA) n/a 173.613 n/a -7.50 76.59 19.94 5.11
CryoLife, Inc. n/a 151.067 36.01 15.74 1.30 1.29 1.46
PharmAthene, Inc. n/a 139.908 n/a -4.46 6.58 6.00 n/a
Celldex Therapeutics, Inc. n/a 119.874 n/a -6.96 8.68 3.27 7.62
SeraCare Life Sciences, Inc. n/a 85.611 12.77 11.03 1.70 1.64 2.83
Aastrom Biosciences, Inc. n/a 74.020 n/a -3.62 4,366.17 29.25 5.95
Hemispherx BioPharma, Inc n/a 68.906 n/a -4.55 464.46 466.35 1.31
Radient Pharmaceuticals Corporation n/a 31.985 n/a n/a 235.94 n/a n/a
Poniard Pharmaceuticals, Inc. n/a 30.929 n/a -1.03 n/a n/a 5.67
Bionovo Inc. n/a 29.436 n/a -1.55 142.23 30.42 3.40
Bioheart, Inc. n/a 8.810 n/a n/a 48.99 n/a n/a
Target
  NeuroMetrix, Inc. n/a 13.397 n/a -0.85 0.79 1.01 0.56

- Defined by the Company - Defined by Others

Dependent Suppliers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  CA, Inc. n/a 12,949.095 16.25 14.07 2.92 2.90 n/a
Computer Sciences Corporation n/a 8,192.297 10.28 9.90 0.51 0.49 4.82
Ariba, Inc. n/a 2,216.960 135.27 89.62 6.14 6.26 27.96
Nektar Therapeutics n/a 1,048.971 n/a -35.47 6.87 6.90 34.45
Halozyme Therapeutics, Inc. n/a 713.088 n/a -13.47 43.23 44.95 20.37
Medidata Solutions, Inc. n/a 589.317 52.47 39.68 3.76 3.66 25.75
CapLease, Inc. n/a 318.520 n/a 8.56 1.89 1.94 0.89
CRA International, Inc. n/a 262.113 78.90 18.59 0.92 0.88 2.44
Dyax Corp. n/a 196.028 n/a -7.25 4.04 3.97 18.66
Flamel Technologies S.A. (ADR) n/a 157.282 n/a -14.81 4.59 3.93 n/a
HealthStream, Inc. n/a 152.855 11.50 40.76 2.42 2.33 5.71
Angiotech Pharmaceuticals, Inc. (USA) n/a 16.610 n/a -0.85 0.07 0.07 n/a

- Defined by the Company - Defined by Others

Key Customers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  DaVita Inc. n/a 6,872.040 15.39 16.25 1.08 1.07 n/a
United Therapeutics Corporation n/a 3,775.311 40.58 30.49 6.91 6.32 4.52
Amylin Pharmaceuticals, Inc. n/a 2,164.254 n/a -11.81 3.18 3.29 6.13
Cerus Corporation n/a 167.878 n/a -8.05 7.59 7.14 19.02
Threshold Pharmaceuticals, Inc. n/a 61.001 n/a -3.12 n/a 4.00 5.44
Accentia Biopharmaceuticals, Inc n/a 40.368 n/a n/a 3.86 n/a n/a
Advanced Life Sciences Holdings, Inc. n/a 4.720 n/a -1.00 2.62 4.61 n/a
Government - United States n/a n/a n/a n/a n/a n/a n/a
The Olayan Group n/a n/a n/a n/a n/a n/a n/a
Government - United Kingdom n/a n/a n/a n/a n/a n/a n/a
PT Enseval Putera Megatrading Tbk n/a n/a n/a n/a n/a n/a n/a
Suhail Bahwan Group (Holding) LLC n/a n/a n/a n/a n/a n/a n/a
Government - Austria n/a n/a n/a n/a n/a n/a n/a
Target
  VHA, Inc. 8.00% n/a n/a n/a n/a n/a n/a
Premier, Inc. n/a n/a n/a n/a n/a n/a n/a

- Defined by the Company - Defined by Others

Key Partners

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  Celgene Corporation n/a 26,369.982 28.50 22.74 7.95 7.43 7.28
Cardinal Health, Inc. n/a 14,412.056 14.78 16.05 0.15 0.14 6.15
DaVita Inc. n/a 6,872.040 15.39 16.25 1.08 1.07 n/a
United Therapeutics Corporation n/a 3,775.311 40.58 30.49 6.91 6.32 4.52
Amylin Pharmaceuticals, Inc. n/a 2,164.254 n/a -11.81 3.18 3.29 6.13
Haemonetics Corporation n/a 1,459.318 23.73 18.23 2.20 2.11 2.46
Nektar Therapeutics n/a 1,048.971 n/a -35.47 6.87 6.90 34.45
The Medicines Company n/a 833.358 n/a 13.96 1.98 1.94 3.93
Halozyme Therapeutics, Inc. n/a 713.088 n/a -13.47 43.23 44.95 20.37
Dyax Corp. n/a 196.028 n/a -7.25 4.04 3.97 18.66
Cerus Corporation n/a 167.878 n/a -8.05 7.59 7.14 19.02
Flamel Technologies S.A. (ADR) n/a 157.282 n/a -14.81 4.59 3.93 n/a
Cornerstone Therapeutics, Inc. n/a 150.017 18.60 10.32 1.21 1.26 3.60
Oncothyreon Inc. n/a 92.270 n/a -5.49 44.95 1,742.15 4.08
Threshold Pharmaceuticals, Inc. n/a 61.001 n/a -3.12 n/a 4.00 5.44
Accentia Biopharmaceuticals, Inc n/a 40.368 n/a n/a 3.86 n/a n/a
Angiotech Pharmaceuticals, Inc. (USA) n/a 16.610 n/a -0.85 0.07 0.07 n/a
Advanced Life Sciences Holdings, Inc. n/a 4.720 n/a -1.00 2.62 4.61 n/a
Suhail Bahwan Group (Holding) LLC n/a n/a n/a n/a n/a n/a n/a
PT Enseval Putera Megatrading Tbk n/a n/a n/a n/a n/a n/a n/a
Vectura Group plc n/a n/a n/a n/a n/a n/a n/a
Cangene Corporation n/a n/a n/a n/a n/a n/a 0.84
The Olayan Group n/a n/a n/a n/a n/a n/a n/a
Takeda Pharmaceutical Company Limited n/a n/a n/a n/a n/a n/a n/a
Innocoll, Inc. n/a n/a n/a n/a n/a n/a n/a

- Defined by the Company - Defined by Others

Financials

  Buyer Target Combined Entity
Income Statement
Operating Items
Revenue 12,815.0 206.8 13,021.8
Other Revenue 0.0 0.0 0.0
Total Revenue 12,815.0 206.8 13,021.8
Cost of Revenue 6,708.0 84.8 6,792.8
SG&A Expense 2,862.0 83.6 2,945.6
Depreciation & Amortization 0.0 0.0 0.0
Research & Development 899.0 20.0 919.0
Interest Expense 0.0 0.0 0.0
Other Operating Expense 0.0 0.0 0.0
Unusual Expense (Income) 0.0 3.1 3.1
Total Expenses 10,469.0 191.5 10,660.5
Operating Income 2,346.0 15.3 2,361.3
Non Operating Items
Interest Expense (Inc.), Net Non-Oprtng -93.0 -0.3 -93.3
Other, Net -115.0 1.5 -113.5
Income Before Taxes 2,138.0 16.5 2,154.5
Income Taxes 561.0 5.6 566.6
Income After Taxes 1,577.0 10.8 1,587.8
Minority Interest (IS) -8.0 0.0 -8.0
Net Income - Excl. Xord. Items 1,569.0 10.8 1,579.8
Net Income - Incl. Xord. Items 1,569.0 10.8 1,579.8
Income Avail. to Common 1,569.0 10.8 1,579.8
Share Items
Basic Avg. Shares Outstanding 584.0 28.2 612.2
Basic EPS - Excl. Xord. Items 2.69 0.38 2.58
Basic EPS - Incl. Xord. Items 2.69 0.38 2.58
Full Dilution Adjustment 0.0 0.0 0.0
Fully Diluted Shares Outstanding 587.0 29.3 616.3
F.D. EPS - Excl. Xord. Items 2.67 0.37 2.56
F.D. EPS - Incl. Xord. Items 2.67 0.37 2.56
Dividends Per Common Share 1.16 0.00 1.16
Balance Sheet
Assets
Cash and Equivalents 2,788.0 42.6 2,830.6
ST Investments 0.0 1.0 1.0
Accounts Receivable 2,205.0 41.0 2,246.0
Inventory 2,500.0 26.3 2,526.3
Prepayments and Advances 647.0 5.0 652.0
Other Current Assets 0.0 4.4 4.4
Current Assets 8,140.0 120.2 8,260.2
PPE 10,450.0 32.7 10,482.7
Accum D&A -5,242.0 -17.0 -5,259.0
PPE, Net 5,208.0 15.8 5,223.8
Goodwill & Intangibles 2,058.0 157.8 2,215.8
Other Assets 0.0 0.0 0.0
Other LT Assets 1,670.0 6.6 1,676.6
Total Assets 17,563.0 300.3 17,863.4
Liabilities
Accounts Payable 0.0 10.0 10.0
Payable/Accrued 3,676.0 0.0 3,676.0
Accrued Expenses 0.0 13.8 13.8
ST Debt 15.0 0.0 15.0
Curr Port of LTD & Cap Lease Oblg 508.0 0.2 508.2
Other (Current) Liabilities 0.0 5.3 5.3
Current Liab. 4,199.0 29.3 4,228.3
LT Debt 4,360.0 0.8 4,360.8
Total LT Debt 4,360.0 0.8 4,360.8
Minority Interest (BS) 232.0 0.0 232.0
Deferred Taxes 0.0 6.5 6.5
Other LT Liab. 2,241.0 7.7 2,248.7
Total Liabilities 11,032.0 44.2 11,076.2
Shareholders Equity
Common Stock 683.0 257.0 940.0
Additional Paid in Capital 5,729.0 0.0 5,729.0
Retained Earnings 7,717.0 12.3 7,729.3
Treasure Stock -5,627.0 0.0 -5,627.0
Other Equity -1,971.0 -13.1 -1,984.1
Total Equity 6,531.0 256.1 6,787.1
Total Liab. & Equity 17,563.0 300.3 17,863.4
Shares Outstanding 581.6 28.8 610.4
Cash Flow
Operating Cash Flow
CF Net Income 1,577.0 11.1 1,588.1
CF Depreciation 678.0 6.4 684.4
CF Deferred Taxes 248.0 0.4 248.4
Other Non-Cash Items 831.0 2.7 833.7
Change in Working Capital -280.0 -12.8 -292.8
Total Cash From Operating Activities 3,054.0 7.9 3,061.9
Investing Cash Flow (not calculated)
Capital Expenditures -1,079.0 -2.7 -1,081.7
Other Investing Cash Flows -287.0 -0.1 -287.1
Total Cash From Investing Activities -1,366.0 -2.8 -1,368.8
Financing Cash Flow (not calculated)
Dividends Paid -676.0 0.0 -676.0
Purchase Or Sale of Stock -1,543.0 2.4 -1,540.6
Purchase and Retirement of Debt 0.0 -0.1 -0.1
Other Financing Cash Flow 319.0 0.3 319.3
Total Cash From Financing Activities -1,307.0 2.6 -1,304.4
Exchange Rate Effects -164.0 0.3 -163.7
Net Change in Cash 217.0 8.0 225.0
Cash Taxes Paid 246.0 3.5 249.5
Cash Interest Paid 113.0 0.0 113.0